The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), Novo Nordisk A/S ...

NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Shares of Virgin Galactic (NYSE:SPCE) surged 10% in premarket trading, while Rocket Lab (NASDAQ:RKLB) rose 3.5%, and Boeing (NYSE:BA) saw a modest 0.5% uptick. The movement comes after an analyst ...

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...